Senescent stromal cells actas chromatin scaffolds that preserve TAD integrity in aged muscle stem cells via juxtacrine lamina-associated domain signaling

Hypothesis

Senescent stromal cells function as physical scaffolds that preserve topologically associating domain (TAD) integrity in aged muscle stem cells through juxtacrine interactions involving lamin‑associated domain (LAD) proteins.

Mechanistic basis

• Senescent fibroblasts and mesenchymal stromal cells retain a distinct nuclear lamina composition enriched in lamin A/C and LAD‑binding proteins such as BAF and LBR[1].
• These lamin‑rich nuclei can form stable cadherin‑mediated adhesions with neighboring muscle stem cells (MuSCs), creating a juxtacrine niche that transmits mechanical cues to the MuSC nucleus.
• Mechanical tension transmitted via N‑cadherin complexes promotes chromatin decondensation at specific LADs, preserving boundary elements and preventing ectopic enhancer‑promoter contacts that would otherwise drive inflammatory gene programs.
• In aged tissue, senescent cells accumulate and maintain this scaffold, while their SASP concurrently suppresses proliferation; the net effect is a trade‑off where architectural support offsets some SASP‑driven dysfunction.
• When senescent cells are cleared by senolytics, the loss of juxtacrine LAD‑lamin contacts leads to rapid erosion of TAD insulation in MuSCs, manifesting as increased inter‑TAD contacts and loss of age‑specific loops[2].

Testable predictions

1. Proximity dependency – MuSCs that are physically isolated from senescent stromal cells (e.g., by transwell separation) will show TAD deterioration comparable to senolytic treatment, even when soluble SASP factors are present.
2. Lamin A/C requirement – Knockdown of lamin A/C in senescent stromal cells will abolish their protective effect on MuSC TADs without altering SASP secretion.
3. Cadherin blockade – Inhibition of N‑cadherin with function‑blocking antibodies will recapitulate the chromatin defects seen after senolysis, whereas E‑cadherin blockade will have no effect.
4. Rescue by synthetic scaffolds – Providing MuSCs with immobilized lamin A/C‑coated beads or engineered senescent‑mimetic fibroblasts will restore TAD boundaries after senolytic clearance.

Experimental approach

• Isolate senescent PDGFRα+ stromal cells from aged mouse muscle and label them with a fluorescent reporter.
• Co‑culture with MuSCs isolated from the same animals, either in direct contact or separated by a 0.4 µm transwell.
• Perform Hi‑C or Micro‑C on MuSCs after 48 h to quantify TAD insulation scores, loop strength, and compartmentalization.
• Parallel conditions: treat with senolytic (dasatinib +  quercetin), lamin A/C siRNA in stromal cells, or N‑cadherin blocking antibody.
• Validate architectural changes by RNA‑seq to detect derepression of SASP‑responsive genes and by functional assays (colony formation, differentiation).

Potential caveats and alternative explanations

• The observed TAD loss could be secondary to increased DNA damage signaling rather than loss of mechanical scaffolding; measuring γH2AX foci will help discriminate.
• Senescent cell heterogeneity means only a subset may possess the lamin‑rich phenotype; single‑cell ATAC‑seq of stromal populations can identify the protective fraction.
• Compensatory upregulation of other matrix proteins after senolysis might mask effects; time‑course experiments are needed to capture early events.

If the hypothesis holds, it reframes senescent cells not merely as inflammatory bystanders but as niche‑integral architects whose physical presence safeguards the 3D genome of stem cells, suggesting that therapeutic strategies should preserve or mimic their structural role while modulating deleterious SASP.